BOLT vs ETR · rev $7.7M vs P/E 28, rev $12.95B
Bolt Biotherapeutics (BOLT) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
BOLT currently screens at market cap $11.3M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the BOLT and ETR stock pages for the full models.
Not investment advice.